JP2003012500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003012500A5 JP2003012500A5 JP2002106425A JP2002106425A JP2003012500A5 JP 2003012500 A5 JP2003012500 A5 JP 2003012500A5 JP 2002106425 A JP2002106425 A JP 2002106425A JP 2002106425 A JP2002106425 A JP 2002106425A JP 2003012500 A5 JP2003012500 A5 JP 2003012500A5
- Authority
- JP
- Japan
- Prior art keywords
- exchange resin
- active ingredient
- functional group
- meq
- unloaded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 10
- 239000004480 active ingredient Substances 0.000 claims 10
- 239000003456 ion exchange resin Substances 0.000 claims 8
- 229920003303 ion-exchange polymer Polymers 0.000 claims 8
- 239000002552 dosage form Substances 0.000 claims 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 4
- 239000003957 anion exchange resin Substances 0.000 claims 4
- 238000010521 absorption reaction Methods 0.000 claims 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 3
- 125000005395 methacrylic acid group Chemical group 0.000 claims 3
- 239000011347 resin Substances 0.000 claims 3
- 229920005989 resin Polymers 0.000 claims 3
- 125000001302 tertiary amino group Chemical group 0.000 claims 3
- 230000002378 acidificating effect Effects 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 239000003729 cation exchange resin Substances 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 125000000524 functional group Chemical group 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 150000007965 phenolic acids Chemical group 0.000 claims 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 229960001193 diclofenac sodium Drugs 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- 229910017464 nitrogen compound Inorganic materials 0.000 claims 1
- 150000002830 nitrogen compounds Chemical group 0.000 claims 1
- 229960002296 paroxetine Drugs 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000575 pesticide Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003335 secondary amines Chemical class 0.000 claims 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 125000002348 vinylic group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28244201P | 2001-04-09 | 2001-04-09 | |
| US60/282442 | 2001-04-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003012500A JP2003012500A (ja) | 2003-01-15 |
| JP2003012500A5 true JP2003012500A5 (2) | 2005-09-15 |
Family
ID=23081536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002106425A Withdrawn JP2003012500A (ja) | 2001-04-09 | 2002-04-09 | 活性成分の延長型放出 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20020176842A1 (2) |
| EP (1) | EP1250920A1 (2) |
| JP (1) | JP2003012500A (2) |
| KR (1) | KR20020079474A (2) |
| TW (1) | TWI242445B (2) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070149409A1 (en) * | 2003-12-29 | 2007-06-28 | Hi-Cap Formulations Ltd. | Pesticide formulations with substituted biopolymers and organic polymers for improving residual activity, droplet size, adherence and rainfastness on leaves and reduction in soil leaching |
| JP2008546835A (ja) * | 2005-06-28 | 2008-12-25 | ユ セ ベ ソシエテ アノニム | 複数の活性薬物−樹脂抱合体 |
| US8187636B2 (en) | 2006-09-25 | 2012-05-29 | Atlantic Pharmaceuticals, Inc. | Dosage forms for tamper prone therapeutic agents |
| US8568777B2 (en) * | 2007-03-30 | 2013-10-29 | Monosol Rx, Llc | Packaged film dosage unit containing a complexate |
| AU2009202778B2 (en) * | 2008-07-11 | 2014-05-08 | Commonwealth of Australia as represented by and acting through the Department of Climate Change, Energy, the Environment and Water | Improved baiting method and composition |
| US10874741B2 (en) * | 2017-08-28 | 2020-12-29 | Spectrix Therapeutics, LLC | Compound to treat Sjogren's syndrome |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4252790A (en) * | 1974-10-23 | 1981-02-24 | Interx Research Corporation | Method for treating gastric ulcer-prone patients |
| HU176215B (en) * | 1978-01-27 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 |
| CH655507B (2) * | 1983-01-12 | 1986-04-30 | ||
| US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
| US5184630A (en) * | 1992-04-06 | 1993-02-09 | Uop | Hair deodorizing compositions and process for using |
| AU666957B2 (en) * | 1992-08-28 | 1996-02-29 | Alcon Laboratories, Inc. | Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| ATE181672T1 (de) * | 1993-04-28 | 1999-07-15 | Takeda Chemical Industries Ltd | Geschmacksmaskierte feste zubereitung und verfahren zur herstellung |
| GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
| AU2286995A (en) * | 1994-04-08 | 1995-10-30 | Alza Corporation | Electrotransport system with ion exchange competitive ion capture |
| AU761949B2 (en) * | 1999-04-13 | 2003-06-12 | Hisamitsu Pharmaceutical Co. Inc. | Iontophoresis device |
-
2002
- 2002-03-26 US US10/107,288 patent/US20020176842A1/en not_active Abandoned
- 2002-04-01 TW TW091106509A patent/TWI242445B/zh not_active IP Right Cessation
- 2002-04-04 KR KR1020020018459A patent/KR20020079474A/ko not_active Withdrawn
- 2002-04-08 EP EP02252512A patent/EP1250920A1/en not_active Withdrawn
- 2002-04-09 JP JP2002106425A patent/JP2003012500A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003012562A5 (2) | ||
| Singh et al. | Ion exchange resins: Drug delivery and therapeutic applications | |
| CO5690538A2 (es) | Formulaciones de multiples particulas de pantoprazol | |
| JP2007531758A5 (2) | ||
| AR029494A1 (es) | Peliculas consumibles oralmente que se disuelven rapidamente que contienen una resina de intercambio de iones como agente que enmascara el sabor | |
| DK1246622T3 (da) | Nye substituerede benzimidazol dosisformer og metoder til deres anvendelse | |
| RU2010153904A (ru) | Ниацин-содержащие композиции с модифицированным высвобождением | |
| ATE303793T1 (de) | Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes | |
| JP2002525313A5 (2) | ||
| AR065072A2 (es) | Una formulacion medicamentosa de pellet de difusion controlada que tiene liberacion controlada de un compuesto activo | |
| JP2016135858A5 (2) | ||
| JP2013144702A5 (2) | ||
| JP2003012500A5 (2) | ||
| JP2008525433A5 (2) | ||
| TWI242446B (en) | Controlled dissolution of active ingredients | |
| RU2008121850A (ru) | Композиции и способы для уничтожения клеток | |
| CN103624853A (zh) | 一种木材表面亲疏可逆开关的制备方法 | |
| Gattani et al. | Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection | |
| PE20001496A1 (es) | Formulacion de liberacion controlada para el tratamiento de epoc | |
| TWI242445B (en) | Extended release of active ingredients | |
| Åkerman et al. | Influence of ionic strength on drug adsorption onto and release from a poly (acrylic acid) grafted poly (vinylidene fluoride) membrane | |
| Gao et al. | Loading and release of amine drugs by ion-exchange fibers: role of amine type | |
| JP2004518016A5 (2) | ||
| WO2009087663A3 (en) | Oral controlled release coated tablet | |
| EP1894629A2 (en) | Method and composition for eliminating odors in ion exchange resins |